Wang Dongke, Duan Chaofan, Zhang Xiaohao, Xu Junying, Hou Xiaohua, Xiang Xuelian
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Neurogastroenterol Motil. 2025 Feb;37(2):e14986. doi: 10.1111/nmo.14986. Epub 2024 Dec 31.
According to the Lyon Consensus 2.0, mean nocturnal baseline impedance (MNBI) greater than 2500 Ω is considered evidence against gastroesophageal reflux disease (GERD). However, we have observed that a subset of GERD patients presents with MNBI exceeding 2500 Ω.
To investigate MNBI characteristics in Chinese GERD patients, identify clinical features of those with normal MNBI, and examine factors influencing MNBI values.
We retrospectively investigated 259 patients with typical reflux symptoms. Demographics, symptoms, proton pump inhibitor (PPI) response, esophageal motility parameters were compared between patients with different AET levels and MNBI levels.
Among the cohort, 38.2% had AET 4%-6%, and 37.5% had AET > 6%. Notably, 95.2% of patients with AET < 4%, 49.5% with AET 4%-6%, and 17.6% with AET > 6% had MNBI > 2500 Ω. Independent risk factors for MNBI > 2500 Ω included the number and duration of supine acid reflux and lower esophageal sphincter (LES) resting pressure. In GERD patients with heartburn, patients with MNBI ≤ 2500 Ω had higher PPI response than MNBI > 2500 Ω (81.1% vs. 55.6%, p = 0.009).
Approximately one-third of Chinese GERD patients have an MNBI > 2500 Ω. The thresholds of MNBI for supporting or ruling out GERD in the Chinese population should be adjusted. MNBI values are independently predicted by the severity of supine acid reflux and the LES resting pressure. GERD patients with mild supine acid reflux may still exhibit normal MNBI levels. Patients with lower MNBI values tend to show better responses to PPI therapy.
根据里昂共识2.0,夜间平均基线阻抗(MNBI)大于2500Ω被视为排除胃食管反流病(GERD)的证据。然而,我们观察到一部分GERD患者的MNBI超过2500Ω。
研究中国GERD患者的MNBI特征,识别MNBI正常患者的临床特征,并探讨影响MNBI值的因素。
我们回顾性研究了259例有典型反流症状的患者。比较了不同酸暴露时间(AET)水平和MNBI水平患者的人口统计学、症状、质子泵抑制剂(PPI)反应及食管动力参数。
在该队列中,38.2%的患者AET为4%-6%,37.5%的患者AET>6%。值得注意的是,AET<4%的患者中95.2%、AET为4%-6%的患者中49.5%以及AET>6%的患者中17.6%的MNBI>2500Ω。MNBI>2500Ω的独立危险因素包括仰卧位酸反流的次数和持续时间以及食管下括约肌(LES)静息压。在有烧心症状的GERD患者中,MNBI≤2500Ω的患者对PPI的反应高于MNBI>2500Ω的患者(81.1%对55.6%,p=0.009)。
约三分之一的中国GERD患者MNBI>2500Ω。在中国人群中支持或排除GERD的MNBI阈值应进行调整。MNBI值可由仰卧位酸反流的严重程度和LES静息压独立预测。仰卧位酸反流较轻的GERD患者可能仍表现出正常的MNBI水平。MNBI值较低的患者对PPI治疗的反应往往更好。